|Dr. Werner Josef Frantsits Ph.D.||Founder and Member of the Supervisory Board||N/A||N/A||N/A|
|Dr. Stefan Welzig||CFO, Chief Technical Officer, Head of Production, Technology & Fin. and Member of the Mgmt Board||N/A||N/A||N/A|
|Dr. Klaus Gerdes||COO, Head of Mktg & Sales, R&D, IR, New Bus. Devel. and Member of the Mgmt Board||N/A||N/A||N/A|
|Dr. Christina Abrahamsberg||CSO, Head of R&D & Veterinary Medicine and Member of the Management Board||N/A||N/A||N/A|
SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients; sterile and semi-sterile liquid, and semi-liquid presentations, such as antibiotics and hormones; clinical diagnostics; and veterinary pharmaceuticals, as well as radiological products, including a range of X-ray imaging agents and the MRT imaging agents. The company's products include Tolperisone, a muscle relaxant; galantamine that is used in an Alzheimer's disease; and PVP hypericine, a patented photoactive substance for use in the diagnosis of urinary bladder cancer. It also researches and develops in therapeutic areas, such as painful muscle spasms/spasticity, and bladder cancer diagnostic; and offers contract manufacturing services. The company was founded in 1990 and is headquartered in Vienna, Austria.
SANOCHEMIA Pharmazeutika AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.